Sunshine Biopharma Inc.

0.31 USD
+0.20 (+182.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Sunshine Biopharma Inc. stock is up 520.4% since 30 days ago. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 May’s closed higher than April.

About Sunshine Biopharma Inc.

Sunshine Biopharma focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin. It also offers Essential 9, a nutritional supplement tablet; and Calcium-Vitamin D supplement.